CERT — CERTARA INC (Healthcare >> Health Information Services)
CERT FAQ
What is CERT's P/E ratio?
CERTARA INC (CERT) currently trades at a P/E ratio of -1,970.02.
What is CERT's ROE?
CERTARA INC reports a Return on Equity (ROE) of -1.48%.
What is CERT's dividend yield?
CERTARA INC offers a dividend yield of 0.00%.
What is CERT's Deepscope Quality Score?
Deepscope rates CERT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CERT?
Deepscope's AI Timing Score for CERT is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CERT belong to?
CERTARA INC is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange.
|
USD 5.37
Price
-0.24
(-4.28%)
Day Change
|
|
|---|
CERT มีคุณภาพโดยรวมยังไม่ดีนัก ( คะแนนปัจจัยพื้นฐาน = 54) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ยังไม่ดีนัก และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...
| ปัจจัยทางคุณภาพ |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 83 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.37 |
| PBV / Sector |
0.86 / 4.52
GREAT
|
| Earning Per Share | -0.09 |
| PE / Sector |
N/A / 45.70
|
| PEG or PE/Growth / Sector |
9.21 / -0.26
|
| Average 1M Daily Value |
21.65 M
GREAT
|
| Average 1W Daily Value |
18.79 M
GREAT
|
| ปัจจัยทางเทคนิค |
|
42% |
| สุขภาพทางการเงิน |
|
50% |
| ประสิทธิภาพการทำกำไร |
|
56% |
| ผลตอบแทนต่อผู้ถือหุ้น |
|
4% |
| รายละเอียดการจดทะเบียน |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CERT |
| Name | CERTARA INC |
| Sector | Healthcare >> Health Information Services |
| Market | NASDAQ |
| Listed Shares | 155.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 872.72 / 3,839.73 |
| ข่าว, ประมาณการ, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4 Radnor Corporate Center, Radnor, PA, United States, 19087
Phone: 415 237 8272
Website: https://www.certara.com
Employees: 1,515
Description: Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
ME vs SECTOR Healthcare >> Health Information Services
Click a bubble to view stock details · Bubble size represents market capitalization share
Google